CARIPRAZINE HYDROCHLORIDE

CARIPRAZINE HYDROCHLORIDE · pharmadog

Patent cliff

source: FDA Orange Book

first barrier falls

Dec 16, 2028

~2.4 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (50)

Mar 17, 2030patentUS 7737142*PED3.7y
Mar 17, 2030patentUS 7737142*PED3.7y
Mar 17, 2030patentUS 7737142*PED3.7y
Mar 17, 2030patentUS 7737142*PED3.7y
Mar 17, 2030patentUS 7737142*PED3.7y
Mar 17, 2030patentUS 7737142*PED3.7y
Jan 16, 2030patentUS RE47350*PED3.5y
Jan 16, 2030patentUS RE47350*PED3.5y
Jan 16, 2030patentUS RE47350*PED3.5y
Jan 16, 2030patentUS RE49110*PED3.5y
Jan 16, 2030patentUS RE49110*PED3.5y
Jan 16, 2030patentUS RE49110*PED3.5y
Jan 16, 2030patentUS RE49110*PED3.5y
Jan 16, 2030patentUS RE49110*PED3.5y
Jan 16, 2030patentUS RE49110*PED3.5y
Jan 16, 2030patentUS RE49302*PED3.5y
Jan 16, 2030patentUS RE49302*PED3.5y
Jan 16, 2030patentUS RE49302*PED3.5y
Jan 16, 2030patentUS RE49302*PED3.5y
Sep 17, 2029compositionUS 77371423.2y
Sep 17, 2029compositionUS 77371423.2y
Sep 17, 2029compositionUS 77371423.2y
Sep 17, 2029compositionUS 77371423.2y
Sep 17, 2029compositionUS 77371423.2y
Sep 17, 2029compositionUS 77371423.2y
Jul 16, 2029method-of-use (U-2545)US RE473503.0y
Jul 16, 2029method-of-use (U-2544)US RE473503.0y
Jul 16, 2029method-of-use (U-2545)US RE473503.0y
Jul 16, 2029method-of-use (U-3503)US RE491103.0y
Jul 16, 2029method-of-use (U-2545)US RE491103.0y
Jul 16, 2029method-of-use (U-2543)US RE491103.0y
Jul 16, 2029method-of-use (U-3503)US RE491103.0y
Jul 16, 2029method-of-use (U-2544)US RE491103.0y
Jul 16, 2029method-of-use (U-3503)US RE491103.0y
Jul 16, 2029method-of-use (U-2545)US RE493023.0y
Jul 16, 2029method-of-use (U-3503)US RE493023.0y
Jul 16, 2029method-of-use (U-2545)US RE493023.0y
Jul 16, 2029method-of-use (U-3503)US RE493023.0y
Jun 20, 2029patentUS 7943621*PED3.0y
Jun 20, 2029patentUS 7943621*PED3.0y
Jun 16, 2029patentUS 7943621*PED2.9y
Jun 16, 2029patentUS 7943621*PED2.9y
Jun 16, 2029patentUS 7943621*PED2.9y
Jun 16, 2029patentUS 7943621*PED2.9y
Dec 20, 2028compositionUS 79436212.5y
Dec 20, 2028compositionUS 79436212.5y
Dec 16, 2028compositionUS 79436212.4y
Dec 16, 2028compositionUS 79436212.4y
Dec 16, 2028compositionUS 79436212.4y
Dec 16, 2028compositionUS 79436212.4y

FDA exclusivities (17)

Jun 18, 2029PEDPediatric (6mo bonus)3.0y
Jun 18, 2029PEDPediatric (6mo bonus)3.0y
Jun 18, 2029PEDPediatric (6mo bonus)3.0y
Jun 18, 2029PEDPediatric (6mo bonus)3.0y
Jun 18, 2029PEDPediatric (6mo bonus)3.0y
Jun 18, 2029PEDPediatric (6mo bonus)3.0y

CARIPRAZINE HYDROCHLORIDE

indications

targets

all catalysts(14)

News(0)

Report a data issue

comments(0)

Patent cliff

patents (50)

FDA exclusivities (17)

🐶 often sniffed alongside